Author

Fabian Ließmann

Center for Scalable Data Analytics and Artificial IntelligenceORCID 0009-0007-9199-1629Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Jens MeileriD· 2 shared Paul EisenhuthiD· 2 shared A.M. EdwardsiD· 1 shared Aiping DongiD· 1 shared Akhila MettuiD· 1 shared Albert Owusu GattoriD· 1 shared Albina Bolotokova· 1 shared Aleksandra IvanováiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Jens MeilerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintMay 1, 2026

Identification of key Y4R residues enables the discovery of selective non-peptide small-molecule agonists

Tim Pelczyk, Corinna Schüß, Mateusz Sklodowski…·Annette Gabriele Beck‐Sickinger

This study identifies key Y4R residues and discovers selective non-peptide small-molecule agonists through molecular docking, residue replacement, and ultra-large library screening.

DOI 10.64898/2026.04.27.721169

humanproteomics

𝕏 PostBluesky

BiochemistryJournal of Chemical Information and ModelingPeer-reviewedNov 5, 2024

CACHE Challenge #1: targeting the WDR domain of LRRK2, a Parkinson's Disease associated protein.

Fengling Li, Suzanne Z. Ackloo, C. H. Arrowsmith…·Matthieu Schapira

The paper evaluates computational hit-finding methods for targeting the WDR domain of LRRK2, a Parkinson's disease protein, finding that diverse strategies yielded weakly potent compounds.

34 citationstop 4%

deep learningdrug response / drug discovery

𝕏 PostBluesky